AstraZeneca is a founding sponsor of the Lung Ambition Alliance and has organised and paid for this article.
For people living with lung cancer, the journey through the healthcare system can be overwhelming. Patient navigation is an essential service that provides coordinated support to help patients and their families from screening and diagnosis through to treatment and survivorship.
Recognising its vital role, the Lung Ambition Alliance is proud to share a new consensus statement, "Patient navigation: improving care and outcomes in lung cancer." Developed by leading members of the global lung cancer patient community, this statement highlights the critical role of patient navigation, identifies current barriers to implementation, and provides practical recommendations to help make this service the standard of care.
The statement outlines how patient navigation can transform the patient experience by reducing delays, improving adherence to treatment, and providing a consistent, reliable point of contact for patients and their families when they need it most.
Read the full consensus statement to learn more about the path forward for embedding patient navigation into lung cancer care for everyone who needs it.
Date of Preparation: July 2026 | Document ID: Z4-83915 | Z4-84885